Full text
Earnings transcript
Read the complete earnings call transcript.
ARCC
Ares Capital Corporation
$19.4
-0.25
(-1.27%)
| Exchange: | NASDAQ |
| Market Cap: | 13.93B |
| Shares Outstanding: | 11.067M |
Delayed data
About The Company
| Sector: | Financial ServicesView sector performance | |||||
| Industry: | Asset ManagementView industry performance | |||||
| CEO: | Kort Schnabel | |||||
| Full Time Employees: | 4250 | |||||
| Address: |
| |||||
| Website: | https://arcc.ares.com |
Ares Capital Corporation (ARCC) operates as a Business Development Company (BDC), delivering diverse financing solutions predominantly to middle-market enterprises. The firm’s expertise lies in facilitating various corporate actions, including funding acquisitions, recapitalizations, and leveraged buyouts. It also extends mezzanine debt, assists with corporate restructurings, and provides crucial rescue financing, in addition to offering growth capital and general refinancing options. ARCC primarily targets investments in companies within the basic and growth manufacturing, business services, consumer products, healthcare (both products and services), and information technology service sectors. Opportunistically, it also explores prospects in industries such as restaurants, retail, oil and gas, and the broader technology space. Geographically, ARCC maintains a broad reach across the United States. Its New York office oversees investments in the Northeast, Mid-Atlantic, Southeast, and Southwest regions. The Chicago office manages opportunities in the Midwest, while its Los Angeles presence covers the Western region. In terms of deal parameters, ARCC typically commits between $20 million and $200 million per investment, with an upper limit of $400 million, targeting companies that generate an EBITDA of $10 million to $250 million. For debt-specific placements, the investment range is generally $10 million to $100 million. The company employs a wide array of financial instruments, including revolving credit facilities, first and second lien loans, unitranche structures, warrants, mezzanine debt, private high yield, junior capital, and subordinated debt, alongside selective non-control preferred and common equity investments. ARCC also evaluates participation in senior and subordinated debt financings led by other parties and strategically acquires stressed or discounted debt. It frequently assumes a lead or agent role in its transactions and actively seeks board representation in its portfolio companies.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 2,166,000 | 2,367,000 | 2,242,000 |
| Gross Profit | 1,636,000 | 1,708,000 | 1,506,000 |
| EBITDA | 1,542,000 | 1,595,000 | 1,398,000 |
| Operating Income | 1,542,000 | 1,595,000 | 1,398,000 |
| Net Income | 1,522,000 | 1,522,000 | 1,299,000 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 23,800,000 | 28,254,000 | 31,235,000 |
| Total Liabilities | 12,599,000 | 14,899,000 | 16,917,000 |
| Total Stockholders Equity | 11,201,000 | 13,355,000 | 14,318,000 |
| Total Debt | 11,935,000 | 13,759,000 | 0 |
| Cash and Cash Equivalents | 535,000 | 635,000 | 638,000 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 511,000 | -2,128,000 | -1,717,000 |
| Capital Expenditure | 0 | 0 | 0 |
| Free Cash Flow | 511,000 | -2,128,000 | -1,717,000 |
| Net Income | 1,522,000 | 0 | 1,415,000 |
| Net Change in Cash | 227,000 | 296,000 | 64,000 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 3,041,100.951 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 3,255,364.948 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 3,148,232.950 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 1,600,604.124 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 1,698,313.706 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 1,649,458.915 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 1,264,218.391 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 1,341,408.961 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 1,302,813.676 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 67,574.205 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 72,335.217 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 69,954.711 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 1.860 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 1.920 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 1.810 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 2 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 3 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
At what price to buy it? -
Intrinsic Value Calculator
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about ARCC valuation
Is Ares Capital Corporation (ARCC) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Ares Capital Corporation (ARCC) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is ARCC a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ARCC trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is ARCC’s P/E ratio?
You can see ARCC’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for ARCC?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is ARCC a good long-term investment?
Whether ARCC fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
ARCC
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-1.27
Trading Metrics:
| Open: | 19.64 | Previous Close: | 19.65 | |
| Day Low: | 19.33 | Day High: | 19.64 | |
| Year Low: | 17.4 | Year High: | 21.64 | |
| Price Avg 50: | 19.47 | Price Avg 200: | 19.27 | |
| Volume: | 4.867M | Average Volume: | 4.729M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
